Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung

Molecular Medicine

Volumn 7, Issue 4, 2001, Pages 240-246

  Kaner, Robert J ^a   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; ISOPROTEIN; LYMPHOKINE; MESSENGER RNA; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN; VASCULOTROPIN A;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; LUNG; LUNG LAVAGE; METABOLISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HUMANS; LUNG; LYMPHOKINES; PROTEIN ISOFORMS; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035317643     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401843     Document Type: Article

References (64)

1. Dvorak HF, Brown LF, Detmar M, Dvorak AM. (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J. Pathol. 146: 1029-1039.
2. Ferrara N, Houck K, Jakeman L, Leung DW. (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13: 18-32.
3. Folkman J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1: 27-31.
4. Ferrara N, Alitalo K. (1999) Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5: 1359-1364.
5. Ferrara N. (1999) Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med 77: 527-543.
6. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13: 9-22.
7. Ozaki H, Seo MS, Ozaki K, Yamada H, Yamada E, Okamoto N, Hofmann F, Wood JM, Campochiaro PA. (2000) Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am. J. Pathol. 156: 697-707.
8. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM. (1998) VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol. Cell 2: 549-558.
9. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985.
10. Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. (1999) Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol. 237: 97-132.
11. Monacci WT, Merrill MJ, Oldfield EH. (1993) Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am. J. Physiol. 264: C995-1002.
12. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. (1992) Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 3: 211-220.
13. Maniscalco WM, Watkins RH, Finkelstein JN, Campbell MH. (1995) Vascular endothelial growth factor mRNA increases in alveolar epithelial cells during recovery from oxygen injury. Am. J. Respir. Cell Mol. Biol. 13: 377-386.
14. Tuder RM, Flook BE, Voelkel NF. (1995) Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J. Clin. Invest. 95: 1798-1807.
15. Bhatt AJ, Amin SB, Chess PR, Watkins RH, Maniscalco WM. (2000) Expression of vascular endothelial growth factor and Flk-1 in developing and glucocorticoid-treated mouse lung. Pediatr. Res. 47: 606-613.
16. Zeng X, Wert SE, Federici R, Peters KG, Whitsett JA. (1998) VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev. Dyn. 211: 215-227.
17. Bhattacharya J. (1998) Physiological basis of pulmonary edema. In Pulmonary Edema. MA Matthay and DH Ingbar, eds. Marcel Dekker: New York, 1-36.
18. Kaner RJ, Ladetto JV, Singh R, Fukuda N, Matthay MA, Crystal RG. (2000) Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am. J. Respir. Cell Mol. Biol. 22: 657-664.
19. Russi TJ, Crystal RG. (1997) Bronchoalveolar lavage. In The Lung: Scientific Foundations. RG Crystal, JB West, ER Weibel, PJ Barnes, eds. Philadelphia: Lippincott-Raven, 371-382.
20. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG, Crystal RG. (1986) Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60: 532-538.
21. Maloney JP, CC Silliman, DR Ambruso, J Wang, RM Tuder, NF Voelkel. (1998) In vitro release of vascular endothelial growth factor during platelet aggregation. Am. J. Physiol. 275: H1054-H1061.
22. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, Selby PJ. (1998) Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br. J. Cancer 77: 956-964.
23. Birkenhager R, Schneppe B, Rockl W. (1996) Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor. Biochem. J. 316: 703-707.
24. Ferrara N, Henzel WJ. (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161: 851-858.
25. Olofsson B, Pajusola K, Euler GV. (1996) Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J. Biol. Chem. 271: 10310-10317.
26. Goto F, Goto K, Weindel K, Folkman J. (1993) Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab. Invest. 69: 50008-50017.
27. Muhlhauser J, Jones M, Yamada I, Cirielli C, Lemarchand P, Gloe TR, Bewig B, Signoretti S, Crystal RG, Capogrossi MC. (1996) Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors. Gene Ther. 3: 145-153.
28. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M. (1990) Nucleotide sequence and expression of a novel human receptor- type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5: 519-524.
29. Gilgenkrantz H, Duboc D, Juillard V, Couton D, Pavirani A, Guillet JG, Briand P, Khan A. (1995) Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: Role of the immune response. Hum. Gene Ther. 6: 1265-1274.
30. Fong GH, Rossant J, Gertsenstein M, Breitman ML. (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70.
31. Kong H-L and Crystal RG. (1998) Gene Therapy Strategies for Tumor Anti-angiogenesis. J. Natl. Cancer Inst 90: 273-286.
32. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66.
33. Waltenberger J, Mayr U, Pentz S. (1996) Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation 94: 1647-1654.
34. Park JE, Keller GA, Ferrara N. 1993 The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 4: 1317-1326.
35. Pepper MS, Ferrara N, Orci L, Montesano R. 1991 Vascular endothelial growth factor (VEGF) induces plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181: 902-906.
36. Lassus P, Ristimaki A, Ylikorkala O, Viinikka L, Andersson S. (1999) Vascular endothelial growth factor in human preterm lung. Am. J. Respir Crit. Care Med. 159: 1429-1433.
37. Christou H, Yoshida A, Arthur V, Morita T, Kourembanas S. (1998) Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 18: 768-776.
38. Fehrenbach H, Kasper M, Haase M, Schuh D, Muller M. (1999) Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: light, fluorescence, and electron microscopy. Anat. Rec. 254: 61-73.
39. Gaudry M, Bregerie O, Andrieu V, El Benna J, Pocidalo MA, Hakim J. (1997) Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 90: 4153-4161.
40. Klagsbrun M and D'Amore PA. 1996 Vascular endothelial growth factor and its receptors. Cytokine & Growth Factor. Reviews. 7: 259-270.
41. Cohen T, Gitay-Goren H, Sharon R, Shibuya M, Halaban R Levin BZ, Neufeld G. (1995) VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J. Biol. Chem. 270: 11322-11326.
42. Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G. (1992) The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem. 267: 6093-6098.
43. Gitay-Goren H, Cohen T, Tessler S, Soker S, Gengrinovitch S, Rockwell P, Klagsbrun M, Levi BZ, Neufeld G. (1996) Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J. Biol. Chem. 271: 5519-5523.
44. Halatek T, Hermans C, Broeckaert F, Wattiez R, Wiedig M, Toubeau G, Falmagne P, Bernard A. (1998) Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur. Respir. J. 11: 726-733.
45. Blaauwgeers HG, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, Partanen TA, Alitalo K, Kroon ME, Kijlstra A, H van, V, et al. (1999) Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am. J. Pathol. 155: 421-428.
46. Hornung D, Lebovic DI, Shifren JL, Vigne JL, Taylor RN. (1998) Vectorial secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells. Fertil. Steril. 69: 909-915.
47. Ku DD, Zaleski JK, Liu S, Brock TA. (1993) Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am. J. Physiol. 265: H586-H592.
48. Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, Isner JM. (1998) Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97: 99-107.
49. Fagan KA, Tyler RC, Sato K, Fouty BW, Morris KGJ, Huang PL, McMurtry IF, Rodman DM. (1999) Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation. Am. J. Physiol. 277: L472-L478.
50. McCabe TJ, Fulton D, Roman LJ, Sessa WC. (2000) Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. J. Biol. Chem 275: 6123-6128.
51. Bouloumie A, Schini-Kerth VB, Busse R. (1999) Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardiovasc. Res. 41: 773-780.
52. Shen BQ, Lee DY, Zioncheck TF. (1999) Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J. Biol. Chem. 274: 33057-33063.
53. Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W. (1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271: 17629-17634.
54. Mastrangeli A, Danel C, Rosenfeld MA, Stratford-Perricaudet L, Perricaudet M, Pavirani A, Lecocq JP, Crystal RG. (1993) Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest 91: 225-234.
55. Rosenfeld MA, Siegfried W, Yoshimura K, Yoneyama K, Fukayama M, Stier LE, Paakko PK, Gilardi P, Stratford-Perricaudet LD, Perricaudet M, et al. (1991) Adenovirus-mediated transfer of a recombinant alpha 1- antitrypsin gene to the lung epithelium in vivo. Science 252: 431-434.
56. Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W, Fukayama M, Bargon J, Stier LE, Stratford-Perricaudet L. (1992) In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68: 143-155.
57. Siegfried W, Rosenfeld M, Stier L, Stratford-Perricaudet L, Perricaudet M, Pavirani A, Lecocq J-P, Crystal RG. (1995) Polarity of secretion of α1-antitrypsin by human respiratory epithelial cells after adenoviral transfer of a human α1- antitrypsin cDNA. Am. J. Respir. Cell Mol. Biol. 12: 379-384.
58. Beinert T, Binder D, Oehm C, Ziemer S, Priem F, Schweigert M, Stuschke M, Fleischhacker M, Siebert G, Mergenthaler HG, et al. (1999) Increased levels of vascular endothelial growth factor in bronchoalveolar lavage of patients with bronchial carcinoma effect of tumour activity and oxidative stress due to radio-chemotherapy? Eur. J. Med. Res. 4: 328-334.
59. Beinert T, Binder D, Oehm C, Ziemer S, Priem F, Stuschke M, Schweigert M, Siebert G, Mergenthaler HG, Schmid P, et al. (2000) Further evidence for oxidant-induced vascular endothelial growth factor up-regulation in the bronchoalveolar lavage fluid of lung cancer patients undergoing radiochemotherapy. J. Cancer Res. Clin. Oncol. 126: 352-356.
60. Partovian C, Adnot S, Eddahibi S, Teiger E, Levame M, Dreyfus P, Raffestin B, Frelin C. (1998) Heart and lung VEGF mRNA expression in rats with monocrotaline-or hypoxiainduced pulmonary hypertension. Am. J. Physiol. 275: H1948-H1956.
61. Arcot SS, Lipke DW, Gillespie MN, Olson JW. (1993) Alterations of growth factor transcripts in rat lungs during development of monocrotaline-induced pulmonary hypertension. Biochem. Pharmacol. 46: 1086-1091.
62. Zachary I, Mathur A, Yla-Herttuala S, Martin J. (2000) Vascular protection: A novel nonangiogenic cardiovascular role for vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 20: 1512-1520.
63. Gerber HP, Dixit V, Ferrara N. (1998) Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and Al in vascular endothelial cells. J. Biol. Chem. 273: 13313-13316.
64. Spyridopoulos I, Brogi E, Kearney M, Sullivan AB, Cetrulo C, Isner JM, Losordo DW. (1997). Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals. J. Mol. Cell Cardiol. 29: 1321-1330.